Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 USD | -3.20% |
|
+8.04% | +3.42% |
06-25 | Oppenheimer Initiates Clearside Biomedical at Outperform With $5 Price Target | MT |
05-13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
Business Summary
Number of employees: 30
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Suprachoroidal Space
100.0
%
| 1 | 100.0 % | 8 | 100.0 % | +519.89% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 8 | 100.0 % | +519.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 07/08/17 |
Charles Deignan
DFI | Director of Finance/CFO | 59 | 31/12/11 |
Susan L. Coultas
CTO | Chief Tech/Sci/R&D Officer | - | 13/06/22 |
Rafael V. Andino
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/13 |
Jenny Kobin
IRC | Investor Relations Contact | - | - |
Viral Kansara
PRN | Corporate Officer/Principal | - | 31/12/17 |
General Counsel | - | 30/11/16 | |
Rick McElheny
PRN | Corporate Officer/Principal | - | 07/11/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 07/08/17 |
Jeffrey Edwards
BRD | Director/Board Member | 63 | 25/09/18 |
Christy Shaffer
BRD | Director/Board Member | 66 | 31/12/11 |
Benjamin Yerxa
BRD | Director/Board Member | 58 | 02/03/22 |
Director/Board Member | 57 | 31/12/11 | |
Richard Croarkin
BRD | Director/Board Member | 69 | 28/02/16 |
Nancy Hutson
BRD | Director/Board Member | 74 | 20/04/20 |
Clay Thorp
CHM | Chairman | 55 | 31/12/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,731,139 | 69,181,973 ( 92.57 %) | 0 | 92.57 % |
Company contact information
Clearside Biomedical, Inc.
900 North Point Parkway Suite 200
30005, Alpharetta
+678 270 3631
http://www.clearsidebio.com![address Clearside Biomedical, Inc.(CLSD)](https://cdn.zonebourse.com/static/address/28377249.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.42% | 93.41M | |
+16.49% | 122B | |
+21.73% | 116B | |
+22.18% | 27.03B | |
-21.81% | 20.36B | |
-16.89% | 16.43B | |
-18.81% | 15.91B | |
-44.74% | 15.6B | |
+62.72% | 14.94B | |
+3.09% | 13.59B |
- Stock Market
- Equities
- CLSD Stock
- Company Clearside Biomedical, Inc.